Severe high-grade dysplasia and in-situ carcinoma of the common bile duct and pancreatic duct

Lancet Oncology

Volumn 4, Issue 6, 2003, Pages 373-375

  Komenaka, Ian K ^a   Mir, Rabia ^a   de Graft Johnson, John B ^a   Wise, Leslie ^a  

^a NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; CLONIDINE; FUROSEMIDE; INSULIN; LOSARTAN;

ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; ASTHMA; BILE DUCT TUMOR; CANCER GRADING; CARCINOMA IN SITU; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CYTOPATHOLOGY; DIABETES MELLITUS; DISEASE SEVERITY; DYSPLASIA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; LABORATORY TEST; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; COMMON BILE DUCT; PATHOLOGY;

AGED; CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; COMMON BILE DUCT; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; PANCREATIC DUCTS;

EID: 0038409827     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(03)01096-9     Document Type: Article

References (21)

1. Frykberg ER. Lobular carcinoma in situ of the breast. Breast J 1999; 5: 296-303.
2. Collard JM. High-grade dysplasia in Barrett's esophagus: the case for esophagectomy. Chest Surg Clin N Am 2002; 12: 77-92.
3. Schafer M, Mullhaupt B, Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 2002; 236: 137-48.
4. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165: 68-72.
5. Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampulla of Vater. A 28-year experience. Ann Surg 1997; 225: 590-99.
6. Furukawa T, Chiba R, Kobari M, et al. Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen. Arch Pathol Lab Med 1994; 118: 227-34.
7. Liu TH, Chen J, Zeng XJ. Histogenesis of pancreatic head and ampullary region carcinoma. Chin Med J (Engl) 1983; 96: 167-74.
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
9. Brat DJ, Lillemoe KD, Yeo CJ, et al. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 1998; 22: 163-69.
10. Rozenblum E, Schutte M, Goggins M, et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 1997; 57: 1731-34.
11. DiGiuseppe JA, Hruban RH, Offerhaus GJ, et al. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994; 144: 889-95.
12. Wilentz RE, Geradts J, Maynard R, et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 1998; 58: 4740-44.
13. Redston MS, Caldas C, Seymour AB, et al. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 1994; 54: 3025-33.
14. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350-53.
15. Day JD, Digiuseppe JA, Yeo C, et al. Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intrepithelial neoplasms. Hum Pathol 1996; 27: 119-24.
16. McCarthy DM, Brat DJ, Wilentz RE, et al. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling. Hum Pathol 2001; 32: 638-42.
17. Wilentz RE, Geradts J, Maynard R, et al. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 1998; 58: 4740-44.
18. Brockie E, Anand A, Albores-Saavedra J. Progression of atypia ductal hyperplasia/carcinoma in situ of the pancreas to invasive carcinoma. Ann Diagn Pathol 1998; 2: 286-92.
19. Brat DJ, Lillemoe KD, Yeo CJ, Warfield PB, Hruban RH. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 1998; 22: 163-69.
20. Agoff SN, Crispin DA, Bronner MP, et al. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Mod Pathol 2001; 14: 139-46.
21. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001; 25: 579-86.